Literature DB >> 28945272

CD4+ T helper cells and regulatory T cells in active lupus nephritis: an imbalance towards a predominant Th1 response?

D Mesquita1, G Mastroianni Kirsztajn2, M F Franco3, L A Reis2, S F Perazzio1, F V Mesquita1, V da Silva Ferreira1, L E Coelho Andrade1, A W Silva de Souza1.   

Abstract

The objective of this study was to evaluate the frequency of CD4+ T cell subsets in peripheral blood mononuclear cells (PBMC), urine and renal tissue from patients with lupus nephritis (LN). PBMC and urinary cells were collected from 17 patients with active LN, 20 disease controls (DC) with primary glomerulonephritis and 10 healthy controls (HC) and were analysed by flow cytometry with markers for T helper type 1 (Th1), Th2, Th17 and regulatory T cells (Treg ) cells. T cell subsets were assessed by immunohistochemistry from LN biopsy specimens from 12 LN patients. T cell subtypes in PBMC were re-evaluated at 6 months of therapy. CD4+ T cells were decreased in PBMC in LN compared with DC and HC (P = 0·0001). No differences were observed in urinary CD4+ T cell subsets between LN and DC. The frequency of urinary Th17 cells was higher in patients with non-proliferative than in proliferative LN (P = 0·041). CD3+ and T-box 21 ( Tbet+) cells were found in glomeruli and interstitium of LN patients, while forkhead box protein 3 (FoxP3), retinoid-related orphan receptor gamma (ROR-γ) and GATA binding protein 3 (GATA-3) were present only in glomeruli. Th1 cells in PBMC were correlated negatively with urinary Th1 cells (Rho = -0·531; P = 0·028) and with Tbet in renal interstitium (Rho = -0·782; P = 0·004). At 6 months, LN patients showed an increase in Th17 cells in PBMC. In conclusion, the inverse association between Th1 cells from PBMC and urinary/renal tissue indicate a role for Th1 in LN pathophysiology. Urinary Th17 cells were associated with less severe LN, and Th17 increased in PBMC during therapy. Urinary CD4+ T cells were not different between LN and DC.
© 2017 British Society for Immunology.

Entities:  

Keywords:  glomerulonephritis; helper T cells; lupus nephritis; regulatory T cells; systemic lupus erythematosus

Mesh:

Substances:

Year:  2017        PMID: 28945272      PMCID: PMC5721248          DOI: 10.1111/cei.13050

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  Proceedings: Various types of antilymphocyte antibodies in patients with systemic lupus erythematosus (SLE) and their relationship with lymphopenia.

Authors:  J B Winfield; R J Winchester; H J Kunkel
Journal:  Arthritis Rheum       Date:  1975 May-Jun

2.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

3.  Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual.

Authors:  Luis M Vilá; Graciela S Alarcón; Gerald McGwin; Holly M Bastian; Barri J Fessler; John D Reveille
Journal:  Arthritis Rheum       Date:  2006-10-15

4.  Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus.

Authors:  M Akahoshi; H Nakashima; Y Tanaka; T Kohsaka; S Nagano; E Ohgami; Y Arinobu; K Yamaoka; H Niiro; M Shinozaki; H Hirakata; T Horiuchi; T Otsuka; Y Niho
Journal:  Arthritis Rheum       Date:  1999-08

5.  The potential role of Th17 cells and Th17-related cytokines in the pathogenesis of lupus nephritis.

Authors:  D-Y Chen; Y-M Chen; M-C Wen; T-Y Hsieh; W-T Hung; J-L Lan
Journal:  Lupus       Date:  2012-08-14       Impact factor: 2.911

6.  Urinary CD4 T cells identify SLE patients with proliferative lupus nephritis and can be used to monitor treatment response.

Authors:  Philipp Enghard; Claudia Rieder; Katharina Kopetschke; J R Klocke; Reinmar Undeutsch; Robert Biesen; Duska Dragun; Maik Gollasch; Udo Schneider; Karlfried Aupperle; Jens Y Humrich; Falk Hiepe; Marina Backhaus; A H Radbruch; Gerd R Burmester; Gabriela Riemekasten
Journal:  Ann Rheum Dis       Date:  2013-03-08       Impact factor: 19.103

7.  Th17 and natural Treg cell population dynamics in systemic lupus erythematosus.

Authors:  Ji Yang; Yiwei Chu; Xue Yang; Di Gao; Lubing Zhu; Xinrong Yang; Linlin Wan; Ming Li
Journal:  Arthritis Rheum       Date:  2009-05

8.  Laser microdissection-based analysis of cytokine balance in the kidneys of patients with lupus nephritis.

Authors:  Y Wang; S Ito; Y Chino; D Goto; I Matsumoto; H Murata; A Tsutsumi; T Hayashi; K Uchida; J Usui; K Yamagata; T Sumida
Journal:  Clin Exp Immunol       Date:  2009-10-06       Impact factor: 4.330

9.  Urinary CD8+ T-cell counts discriminate between active and inactive lupus nephritis.

Authors:  Sebastian Dolff; Wayel H Abdulahad; Suzanne Arends; Marcory C R F van Dijk; Pieter C Limburg; Cees G M Kallenberg; Marc Bijl
Journal:  Arthritis Res Ther       Date:  2013-02-27       Impact factor: 5.156

10.  CD8⁺ Treg cells associated with decreasing disease activity after intravenous methylprednisolone pulse therapy in lupus nephritis with heavy proteinuria.

Authors:  Yi-Giien Tsai; Chia-Ying Lee; Tze-Yi Lin; Ching-Yuang Lin
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

View more
  12 in total

Review 1.  Treg cells in autoimmunity: from identification to Treg-based therapies.

Authors:  Lisa Göschl; Clemens Scheinecker; Michael Bonelli
Journal:  Semin Immunopathol       Date:  2019-04-05       Impact factor: 9.623

2.  Th17 and Th1 cells in systemic lupus erythematosus with focus on lupus nephritis.

Authors:  Raouia Fakhfakh; Zeineb Zian; Nesrine Elloumi; Olfa Abida; Emna Bouallegui; Hana Houssaini; Elisabetta Volpe; Alessia Capone; Hend Hachicha; Sameh Marzouk; Zouhir Bahloul; Hatem Masmoudi
Journal:  Immunol Res       Date:  2022-06-06       Impact factor: 4.505

3.  Facilitated expansion of Th17 cells in lupus nephritis patients.

Authors:  B Jakiela; J Kosałka; H Plutecka; S Bazan-Socha; M Sanak; J Musiał
Journal:  Clin Exp Immunol       Date:  2018-09-23       Impact factor: 4.330

Review 4.  Immune-Related Urine Biomarkers for the Diagnosis of Lupus Nephritis.

Authors:  María Morell; Francisco Pérez-Cózar; Concepción Marañón
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

5.  Accelerated and Severe Lupus Nephritis Benefits From M1, an Active Metabolite of Ginsenoside, by Regulating NLRP3 Inflammasome and T Cell Functions in Mice.

Authors:  Tsai-Jung Lin; Chung-Yao Wu; Pei-Yi Tsai; Wan-Han Hsu; Kuo-Feng Hua; Ching-Liang Chu; Yu-Chieh Lee; Ann Chen; Sheau-Long Lee; Yi-Jin Lin; Chih-Yu Hsieh; Shin-Ruen Yang; Feng-Cheng Liu; Shuk-Man Ka
Journal:  Front Immunol       Date:  2019-08-14       Impact factor: 7.561

6.  The Regulatory T Cell in Active Systemic Lupus Erythematosus Patients: A Systemic Review and Meta-Analysis.

Authors:  Wenli Li; Chuiwen Deng; Hanbo Yang; Guochun Wang
Journal:  Front Immunol       Date:  2019-02-18       Impact factor: 7.561

Review 7.  Treatment of Lupus Nephritis from Iranian Traditional Medicine and Modern Medicine Points of View: A Comparative Study.

Authors:  Yasaman Vahedi-Mazdabadi; Mina Saeedi
Journal:  Evid Based Complement Alternat Med       Date:  2021-11-09       Impact factor: 2.629

Review 8.  Follicular Regulatory T Cells in Systemic Lupus Erythematosus.

Authors:  Xin Xia; Jun Yang; Shengjun Wang
Journal:  J Immunol Res       Date:  2021-07-13       Impact factor: 4.818

Review 9.  The Proportion of Regulatory T Cells in Patients with Systemic Lupus Erythematosus: A Meta-Analysis.

Authors:  Sheng-Xiao Zhang; Xiao-Wen Ma; Yu-Feng Li; Na-Ling Lai; Ze-Hao Huang; Kai Fan; Cai-Hong Wang; Xiao-Feng Li
Journal:  J Immunol Res       Date:  2018-09-03       Impact factor: 4.818

Review 10.  IL-17A as a Potential Therapeutic Target for Patients on Peritoneal Dialysis.

Authors:  Vanessa Marchant; Antonio Tejera-Muñoz; Laura Marquez-Expósito; Sandra Rayego-Mateos; Raul R Rodrigues-Diez; Lucia Tejedor; Laura Santos-Sanchez; Jesús Egido; Alberto Ortiz; Jose M Valdivielso; Donald J Fraser; Manuel López-Cabrera; Rafael Selgas; Marta Ruiz-Ortega
Journal:  Biomolecules       Date:  2020-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.